Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Wood

Showing results (321-330 of 369) with videos related to

Pageof 37
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|December 26, 2009
Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settingsSuely Hiromi Tuboi, Antonio Guilherme Pacheco, Lee H Harrison, et al.
AIDS (London, England)|October 25, 2016
Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?Alana T Brennan, Mary-Ann Davies, Jacob Bor, et al.
AIDS (London, England)|February 13, 2022
Effect of antiretroviral therapy care interruptions on mortality in children living with HIVClaire Davies, Leigh Johnson, Shobna Sawry, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2009
Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patientsTihana Bicanic, Conrad Muzoora, Annemarie E Brouwer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 15, 2024
Tuberculosis Preventive Treatment for Pregnant People With Human Immunodeficiency Virus in South Africa: A Modeling Analysis of Clinical Benefits and RisksLinzy V Rosen, Acadia M Thielking, Caitlin M Dugdale, et al.
Plos Medicine|November 5, 2004
Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1Frank van Leth, Prahpan Phanuphak, Erik Stroes, et al.
The Journal of Antimicrobial Chemotherapy|June 12, 2018
2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settingsAndrew D Revell, Dechao Wang, Maria-Jesus Perez-Elias, et al.
AIDS (London, England)|February 21, 2012
Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trialSarah B Lorenzana, Michael D Hughes, Beatriz Grinsztejn, et al.
Lancet (London, England)|June 19, 2010
Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trialIan Sanne, Catherine Orrell, Matthew P Fox, et al.
AIDS (London, England)|June 18, 2009
Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring, Olivia Keiser, Hannock Tweya, et al.
Pageof 37

Showing results (321-330 of 369) with videos related to

Sort By:
Pageof 37
Journal of Acquired Immune Deficiency Syndromes (1999)|December 26, 2009
Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settingsSuely Hiromi Tuboi, Antonio Guilherme Pacheco, Lee H Harrison, et al.
AIDS (London, England)|October 25, 2016
Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?Alana T Brennan, Mary-Ann Davies, Jacob Bor, et al.
AIDS (London, England)|February 13, 2022
Effect of antiretroviral therapy care interruptions on mortality in children living with HIVClaire Davies, Leigh Johnson, Shobna Sawry, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2009
Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patientsTihana Bicanic, Conrad Muzoora, Annemarie E Brouwer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 15, 2024
Tuberculosis Preventive Treatment for Pregnant People With Human Immunodeficiency Virus in South Africa: A Modeling Analysis of Clinical Benefits and RisksLinzy V Rosen, Acadia M Thielking, Caitlin M Dugdale, et al.
Plos Medicine|November 5, 2004
Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1Frank van Leth, Prahpan Phanuphak, Erik Stroes, et al.
The Journal of Antimicrobial Chemotherapy|June 12, 2018
2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settingsAndrew D Revell, Dechao Wang, Maria-Jesus Perez-Elias, et al.
AIDS (London, England)|February 21, 2012
Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trialSarah B Lorenzana, Michael D Hughes, Beatriz Grinsztejn, et al.
Lancet (London, England)|June 19, 2010
Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trialIan Sanne, Catherine Orrell, Matthew P Fox, et al.
AIDS (London, England)|June 18, 2009
Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring, Olivia Keiser, Hannock Tweya, et al.
Pageof 37